Work

Abstract 2286: Monitoring response to camizestrant next-generation oral SERD in ER+ advanced breast cancer patient-derived xenografts via circulating tumor DNA profiling

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-2286

Authors: Susana Ros, Paul Labrousse, Hugh Russell, Fryer Henderson, Sara Talbot, Benjamin Phillips, Teresa Klinowska, Christopher Morrow, Claire Crafter, Daniel Stetson, Darren Hodgson, James Hadfield

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148773132

Cites:

Cited by:

Related to: